This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below.
Jaydess®▼ (13.5mg levonorgestrel)
Not currently promoted but still available.
Jaydess®▼ (13.5mg intrauterine delivery system levonorgestrel) is an IUS indicated for contraception for up to 3 years.
Kyleena (levonorgestrel 19.5mg intrauterine delivery system) prescribing information
Have you thought about Kyleena?
Kyleena®: smallest T-body and narrowest insertion tube available in a 5-year IUS
- Placement of Kyleena® is considered easy by healthcare professionals in 90% (n=1452) of women, regardless of parity.
- Women rated the pain of placement as ‘none’ or mild’ in 65% (n=1452) of cases.
Open-label extended trial involving 1453 women to evaluate efficacy, safety, tolerability of Kyleena for up to 5 years of use
PP-PF-WHC-IUS-GB-0106 | March 2025
- Referencesexpand_less
- 1Nelson AL, et al. Expert Rev Clin Pharmacol, 2017;10(8):833–842.
- 2Bayer Plc. Kyleena® 19.5mg intrauterine delivery system (levonorgestrel): Summary of Product Characteristics [online]. Updated December 2021. Available at: https://www.medicines.org.uk/emc/product/769/smpc (Last Accessed February 2024)
- 3Bayer Plc. Jaydess®▼ 13.5mg intrauterine delivery system (levonorgestrel): Summary of Product Characteristics [online]. Updated December 2021. Available at: https://www.medicines.org.uk/emc/product/5297/smpc (Last Accessed February 2024)